Form 4: Labcorp Officer Reports Routine Stock Transactions
Insider Transaction Report
Labcorp's SVP and Chief Accounting Officer, Peter J. Wilkinson, reported recent acquisitions of common stock through RSU vesting and subsequent dispositions for tax obligations.
Summary
- Peter J. Wilkinson, SVP, Chief Accounting Officer of Labcorp Holdings Inc. (LH), reported multiple transactions involving the company's common stock.
- On February 6, 2026, 133 shares of common stock were acquired through the vesting of Restricted Stock Units (RSUs).
- On the same date, 45 shares of common stock were disposed of at a price of $277.20 per share to satisfy tax withholding obligations.
- On February 7, 2026, an additional 134 shares of common stock were acquired through the vesting of RSUs.
- On February 9, 2026, 46 shares of common stock were disposed of at a price of $274.01 per share to satisfy tax withholding obligations.
- Following these transactions, Peter J. Wilkinson directly beneficially owned 2,028.2194 shares of common stock.
- The RSUs that vested on February 6, 2026, were part of a grant that vests in three equal annual installments beginning on February 6, 2025.
- The RSUs that vested on February 7, 2026, were part of a grant that vested in three equal annual installments beginning on February 7, 2024, and are now fully vested.
- The aggregate number of Restricted Stock Units held by the reporting person was 2,358 after the February 6, 2026 transaction and 2,224 after the February 7, 2026 transaction.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. It represents routine insider compensation and tax-related transactions, which are expected and do not indicate any significant positive or negative operational or financial developments for the company.
Positives
- The vesting of Restricted Stock Units indicates a component of executive compensation being realized, aligning management's interests with shareholder value.
- The acquisition of shares through RSU vesting increases the reporting person's direct beneficial ownership of company stock.
Future Outlook
The filing details past and current insider transactions and does not provide specific forward-looking statements or guidance regarding the company's future performance or strategic direction, beyond the pre-scheduled vesting of RSUs.
Industry Context
StockSavvy.ai notes that Form 4 filings are specific to individual insider transactions and do not typically provide broader industry context or trends. These transactions reflect routine compensation and tax management for a senior executive within the healthcare diagnostics industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Delegation of Authority | Peter J. Wilkinson executed a Power of Attorney on January 6, 2026, appointing Kathryn W. Kyle as his attorney-in-fact to execute and file Forms 3, 4, and 5 with the SEC on his behalf. | 01/06/2026 | This streamlines the compliance process for Section 16 filings for the reporting person, ensuring timely and accurate disclosures. |
Stakeholder Impact
- Shareholders: The transactions are routine and reflect standard executive compensation practices, with minimal direct impact on the broader shareholder base.
- Employees: No direct impact on employees is indicated by this filing.
Next Steps
- Future vesting events for the remaining Restricted Stock Units will occur according to their pre-determined schedules.
Key Dates
| Date | Description |
|---|---|
| 02/07/2024 | Start of three equal annual installments for a grant of Restricted Stock Units, which are now fully vested as of February 7, 2026. |
| 02/06/2025 | Start of three equal annual installments for a grant of Restricted Stock Units, with a portion vesting on February 6, 2026. |
| 01/06/2026 | Date the Power of Attorney was executed, appointing Kathryn W. Kyle as attorney-in-fact for Section 16 filings. |
| 02/06/2026 | Transaction date for the acquisition of 133 shares via RSU vesting and disposition of 45 shares for tax withholding. |
| 02/07/2026 | Transaction date for the acquisition of 134 shares via RSU vesting. |
| 02/09/2026 | Transaction date for the disposition of 46 shares for tax withholding. |
| 02/10/2026 | Signature date of the Form 4 filing. |
Keywords
Labcorp Holdings Inc., LH, Form 4, Insider Trading, Restricted Stock Units, RSU Vesting, Stock Compensation, Executive Compensation, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.